Glaukos Corp GKOS
NYSE · United States · Health Technology
$163.57-0.62 (-0.38%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-29 | -0.14 | -0.21 | +33.5% | $185.61M | +23.0% | +11.4%$151.33→$168.52 |
| Q1 2026 | 2026-04-29 | -0.18 | -0.28 | +35.7% | — | — | +20.1%$119.63→$143.67 |
| Q4 2025 | 2026-02-17 | -0.28 | -0.20 | -40.0% | — | — | +10.5%$109.47→$121.00 |
| Q3 2025 | 2025-10-29 | -0.16 | -0.26 | +38.5% | — | — | +12.9%$77.79→$87.80 |
| Q2 2025 | 2025-07-30 | -0.24 | -0.26 | +7.7% | — | — | — |
| Q1 2025 | 2025-04-30 | -0.22 | -0.35 | +37.1% | — | — | — |
| Q4 2024 | 2025-02-20 | -0.40 | -0.39 | -2.6% | — | — | — |
| Q3 2024 | 2024-11-04 | -0.28 | -0.48 | +41.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.